Simon Winter Institute for Human Genetics, B'nai Zion Medical Center, P.O.B 4940, 31048, Haifa, Israel.
Genetic Unit, Ziv Medical Center, Safed, Israel.
Orphanet J Rare Dis. 2018 Mar 15;13(1):41. doi: 10.1186/s13023-018-0769-7.
Thoracic and abdominal aortic aneurysms and dissection often develop in hypertensive elderly patients. At higher risk are smokers and those who have a family history of aortic aneurysms. In most affected families, the aortic aneurysms and dissection is inherited in an autosomal dominant manner with decreased penetrance and variable expressivity. Mutations at two chromosomal loci, TAA1 at 11q23 and the TAA2 at 5q13-14, and eight genes, MYLK, MYH11, TGFBR2, TGFBR1, ACTA2, SMAD3, TGFB2, and MAT2A, have been identified as being responsible for the disease in 23% of affected families.
Herein, we inform on the clinical, genetic and pathological characteristics of nine living and deceased members of a large consanguineous Arab family with thoracic aortic aneurysm and dissection who carry a missense mutation c.4471G > T (Ala1491Ser), in exon 27 of MYLK gene. We show a reduced kinase activity of the Ala1491Ser protein compared to wildtype protein. This mutation is expressed as aortic aneurysm and dissection in one of two distinct phenotypes. A severe fatal and early onset symptom in homozygous or mild late onset in heterozygous genotypes.
We found that MYLK gene Ala1491Ser mutation affect the kinase activity and clinically, it presents with vascular aneurysms and dissection. We describe a distinct genotype phenotype correlation where; heterozygous patients have mild late onset and incomplete penetrance disease compared with the early onset severe and generally fatal outcome in homozygous patients.
胸主动脉瘤和夹层在高血压老年患者中常发生。高危因素包括吸烟者和有主动脉瘤家族史者。在大多数受影响的家族中,主动脉瘤和夹层以常染色体显性遗传方式遗传,外显率降低,表现度可变。在两个染色体位点 TAA1(11q23)和 TAA2(5q13-14)以及八个基因 MYLK、MYH11、TGFBR2、TGFBR1、ACTA2、SMAD3、TGFB2 和 MAT2A 中发现突变,导致 23%的受影响家族患病。
在此,我们报告了一个大型阿拉伯近亲家族中 9 名生存和已故成员的临床、遗传和病理学特征,他们携带 MYLK 基因外显子 27 中的错义突变 c.4471G>T(Ala1491Ser)。我们显示 Ala1491Ser 蛋白的激酶活性低于野生型蛋白。该突变表现为主动脉瘤和夹层,具有两种不同的表型之一。纯合子表现为严重的致命和早发症状,杂合子表现为轻微的晚发症状。
我们发现 MYLK 基因 Ala1491Ser 突变影响激酶活性,临床上表现为血管动脉瘤和夹层。我们描述了一种明显的基因型表型相关性,杂合子患者的晚发症状较轻,外显率不完全,而纯合子患者的早发症状严重,通常致命。